tiprankstipranks
Trending News
More News >
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Financial Statements

Compare
162 Followers

Revelation Biosciences Financial Overview

Revelation Biosciences's market cap is currently $3.15M. The company's EPS TTM is $-139.82; its P/E ratio is ―; Revelation Biosciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-6.88. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -25.05K$ -40.01K$ -69.17K$ 0.00
Operating Income$ -7.98B$ -8.66M$ -10.86M$ -11.95M$ -145.49K
EBITDA$ -7.98B$ -95.21K$ -10.84M$ -11.93M$ -145.49K
Net Income$ -15.04B$ -120.25K$ -10.79M$ -11.99M$ -1.63M
Balance Sheet
Cash & Short-Term Investments$ 6.50B$ 11.99M$ 5.25M$ 1.27M$ 4.49M
Total Assets$ 6.62B$ 12.21M$ 5.50M$ 2.04M$ 4.62M
Total Debt$ 0.00$ 0.00$ 0.00$ 16.75K$ 0.00
Net Debt$ -6.50M$ -11.99M$ -5.25M$ -1.26M$ -4.49M
Total Liabilities$ 1.91B$ 5.56M$ 4.45M$ 2.14M$ 1.21M
Stockholders' Equity$ 4.71B$ 6.65M$ 1.05M$ -99.47K$ 3.41M
Cash Flow
Free Cash Flow$ -18.34B$ -7.29M$ -11.22M$ -11.22M$ -215.07K
Operating Cash Flow$ -18.32B$ -7.29M$ -11.22M$ -11.09M$ -215.07K
Investing Cash Flow$ -19.17M$ 0.00$ 0.00$ -131.96K$ -74.04M
Financing Cash Flow$ 12.85B$ 14.03M$ 15.20M$ 8.00M$ 74.26M
Currency in USD

Revelation Biosciences Earnings and Revenue History

Revelation Biosciences Debt to Assets

Revelation Biosciences Cash Flow

Revelation Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis